Mechanistically, <i>in vitro</i> and <i>in vivo</i> silencing of UCP2 significantly impairs acute myeloid leukemia cell growth and survival, accompanied by the disruption of mitochondrial homeostasis. The gene discussed is UCP2; the disease is acute myeloid leukemia.